ACRO Biomedical Co., Ltd.

ACRO Biomedical Co., Ltd.

TTPEX:6748
185.00
TWD
-6.00
(-3.14%)
12.07BMarket Cap

Latest Stock Split

Nov 24, 2025

95:94

For every 94 shares held, investors received 95. The price per share adjusted from $60.20 to $59.57.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data

Stock Split History

  1. Nov 24, 2025
    Before$60.20
    Split ratio95:94
    After$59.57
    Forward
  2. Oct 12, 2023
    Before$36.30
    Split ratio981:976
    After$36.11
    Forward
  3. Feb 08, 2022
    Before$25.45
    Split ratio300:283
    After$24.01
    Forward

About ACRO Biomedical Co., Ltd. stock splits

ACRO Biomedical Co., Ltd. (TPEX:6748) operates in the Medical specialties industry.

ACRO Biomedical Co., Ltd. company overview

When did ACRO Biomedical Co., Ltd. stock split?

ACRO Biomedical Co., Ltd.'s most recent stock split was on November 24, 2025. It was a 95-for-94 forward split, so shareholders received 95 shares for every 94 they held.

What is ACRO Biomedical Co., Ltd.'s stock split history?

ACRO Biomedical Co., Ltd. (TPEX:6748) has split its stock 3 times: a 300-for-283 split on February 8, 2022, a 981-for-976 split on October 12, 2023, and a 95-for-94 split on November 24, 2025.

How many times has ACRO Biomedical Co., Ltd. stock split?

ACRO Biomedical Co., Ltd. has split its stock 3 times. This history records 3 forward splits between February 8, 2022 and November 24, 2025.

What is a stock split?

A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In ACRO Biomedical Co., Ltd.'s 95-for-94 split on November 24, 2025, every 94 shares became 95 shares.

Will ACRO Biomedical Co., Ltd. split its stock again?

ACRO Biomedical Co., Ltd. has not announced a new split in our records. Its most recent split was on November 24, 2025, less than a year ago. Companies announce splits in advance, and any new TPEX:6748 split will appear on this page.